Partilhar
Informação da revista
Número
Vol. 42. Núm. 9.Páginas 749-820 (Setembro 2023)
Original articles
Coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement: Feasibility in clinical practice
Gualter Silva, Mariana Silva, Cláudio Guerreiro, Francisco Sampaio, Gustavo Pires-Morais, Lino Santos, Bruno Melica, Alberto Rodrigues, ... Ricardo Fontes-Carvalho
Rev Port Cardiol. 2023;42:749-56
Acesso de texto completo
Original articles
Editorial comment
Difficult coronary access after transcatheter aortic valve implantation: Brace for impact!
Ruben Ramos, Duarte Cacela
Rev Port Cardiol. 2023;42:757-8
Acesso de texto completo
Impact of the use of cusp-overlap projection on the incidence of permanent pacemaker implantation post-transcatheter aortic valve implantation with self-expanding valves
Ana Rita Moura, José Alberto Rodrigues, Pedro Braga, Bruno Melica, Lino Santos, Gustavo Pires-Morais, Francisco Sampaio, Ricardo Fontes-Carvalho
Rev Port Cardiol. 2023;42:759-69
Acesso de texto completo
Original articles
Editorial comment
The cusp-overlap technique for reducing pacemaker implantation after transcatheter aortic valve implantation: Game-changer or gimmick?
Miguel Nobre Menezes
Rev Port Cardiol. 2023;42:771-3
Acesso de texto completo
Post-infarction ventricular septal defect surgery in Portugal
Pedro Magro, André Soeiro, Nuno Guerra, Gonçalo Coutinho, Pedro Antunes, Ângelo Nobre, José Neves, Miguel Sousa-Uva
Rev Port Cardiol. 2023;42:775-83
Acesso de texto completo
Original articles
Editorial comment
National registries for rare clinical conditions: Networking to promote evidence-based healthcare
Adelino F. Leite-Moreira, Francisca Saraiva
Rev Port Cardiol. 2023;42:785-6
Acesso de texto completo
Predictive value of a positive stress single-photon emission computed tomography or stress cardiac magnetic resonance for ruling in obstructive coronary artery disease in a real-world setting
Cláudia Silva, Pedro Lopes, Mariana Gonçalves, António Ventosa, João Calqueiro, Pedro Freitas, Sara Guerreiro, João Brito, ... António Miguel Ferreira
Rev Port Cardiol. 2023;42:787-93
Acesso de texto completo
Original articles
Editorial comment
Predictive value of a positive stress single-photon emission computed tomography or stress cardiac magnetic resonance for ruling in obstructive coronary artery disease in a real-world setting
Pedro Matos
Rev Port Cardiol. 2023;42:795-6
Acesso de texto completo
State of the art
Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol
Francisca Gomes da Silva, Rita Calça, Ana Rita Martins, Inês Araújo, Carlos Aguiar, Cândida Fonseca, Patrícia Branco
Rev Port Cardiol. 2023;42:797-803
Acesso de texto completo
Case report
Glossopharyngeal neuralgia with cardioinhibitory syncope: Is a permanent pacemaker required?
Ana Marques, Daniel Caldeira, Sofia Alegria, Ana Rita Pereira, Isabel João, Hélder Pereira
Rev Port Cardiol. 2023;42:805-9
Acesso de texto completo
Case Report
Editorial comment
Reflex syncope: Insights into physiology
Guilherme Portugal
Rev Port Cardiol. 2023;42:811-2
Acesso de texto completo
Image in cardiology
Percutaneous implantation of a Sapiens 3 valve-in-valve in mitral position: A case report involving correction of prosthetic mitral valve regurgitation
Miguel Martins de Carvalho, Ricardo Alves Pinto, Tânia Proença, Mariana Paiva, Carla Sousa, João Carlos Silva, Filipe Macedo
Rev Port Cardiol. 2023;42:813-4
Acesso de texto completo
Letter to the editor
RAAS inhibitors in COVID-19: They are not all the same!
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Rev Port Cardiol. 2023;42:815-6
Acesso de texto completo
Reply to: RAAS inhibitors in COVID-19: Not all are created equal!
Jorge Gonçalves, Catarina D. Santos, Paula Fresco, Fernando Fernandez-Llimos
Rev Port Cardiol. 2023;42:817-8
Acesso de texto completo
In memoriam
Conteúdo especial sobre COVID-19
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus
- Percutaneous coronary intervention in chronic total occlusions: Should it be avoided in type 2 diabetic patients?
- RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.